Novartis India posts Q4 FY24 net profit lower at Rs. 14.68 Cr
Cipla posts Q4 FY24 consolidated PAT at Rs. 939.04 Cr
Dr. Lal PathLabs posts Q4 FY24 consolidated PAT at Rs. 84.5 Cr
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes